NYSEAM • LCTX • US53566P1093
Generating your data highlights...
247m USD | # 7198 in US
1.23m shares | 1.29m USD
252.91m
75.48% | 190.9m
Lineage Cell Therapeutics (NYSEAM: LCTX) has a market capitalization of $247.42M. Last close $0.98 (as of 2026-10-19); 52-week range $0.88 to $2.09.